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The Impact of Cardiovascular Risk Factors on Aortic
Stiffness and Wave Reflections Depends on Age
The Anglo-Cardiff Collaborative Trial (ACCT III)
Carmel M. McEniery, Yasmin, Kaisa M. Maki-Petaja, Barry J. McDonnell, Margaret Munnery,
Stacey S. Hickson, Stanley S. Franklin, John R. Cockcroft, Ian B. Wilkinson, on behalf of the
Anglo-Cardiff Collaboration Trial (ACCT) Investigators
Abstract—Ageing exerts differential effects on arterial stiffness and wave reflections. However, the impact of
cardiovascular risk factors on arterial stiffness and wave reflections and, particularly, how such effects are influenced
by ageing has not been assessed within a single large population, covering a sufficiently wide age range. Therefore, we
determined the extent to which age alters the impact of traditional cardiovascular risk factors on arterial stiffness and
wave reflections. Aortic stiffness and wave reflections were assessed in 4421 individuals (age range 18 to 92 years).
When treated as continuous variables, clinic systolic, diastolic, and pulse pressures and glucose levels were
independently associated with stiffness, and, with the exception of diastolic pressure, these associations were more
marked in older individuals. In contrast, clinic systolic and diastolic pressures and smoking were independently
associated with wave reflections, with stronger associations observed in younger individuals. The impact of traditional
cardiovascular risk factors on arterial stiffness and wave reflections is strongly dependent on age and is largely driven
by blood pressure. Additional studies are required to assess the impact of these arterial measures on cardiovascular
outcome within a single population. (Hypertension. 2010;56:591-597.)
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Ageing exerts a marked influence on the cardiovascularsystem. One of the more apparent effects is large artery
stiffening or arteriosclerosis,1 which is now recognized as a
key, independent determinant of cardiovascular risk.2 In
addition, increased arterial wave reflections also predict
outcome in several patient groups.2 We recently reported3 a
nonlinear relationship between healthy ageing and 2 com-
monly used indices of large artery hemodynamics: aortic
pulse wave velocity (aPWV), a direct measure of arterial
stiffness, and aortic augmentation index (AIx), a composite
measure of wave reflections. In particular, the age-related
changes in aPWV were significantly greater in individuals
50 years of age, whereas the changes in AIx were more
marked in younger individuals. This led us to hypothesize
that aPWV may provide a more sensitive indication of arterial
ageing in older individuals, whereas AIx may be a more
sensitive marker in younger individuals, although this hy-
pothesis3 remains to be tested.
Interestingly, increased arterial stiffness has been reported
in individuals with cardiovascular risk factors such as hyper-
tension,4–6 hypercholesterolemia,7–9 cigarette smoking,10–12
and diabetes,13–15 leading to the popular concept that such
individuals may experience premature vascular ageing in
relation to healthy individuals. However, these studies have
used a wide variety of methodologies to assess arterial
stiffness, in relatively small populations of differing ages,
leading to inconsistent findings. A recent systematic review
suggested that age and blood pressure (BP) explain the
majority of the observed variance in arterial stiffness, with
other factors having little or no effect.16 However, as yet,
there has been no systematic analysis of the relative impact of
cardiovascular risk factors on large artery properties, con-
ducted within a single population, covering a sufficiently
wide age range. Moreover, the extent to which ageing alters
the effect of cardiovascular risk factors on arterial stiffness
and wave reflections has not been well described.
The aim of the present study was to determine the relative
impact of cardiovascular risk factors on arterial stiffness and
wave reflections in a large cohort of individuals from the
Anglo-Cardiff Collaborative Trial (ACCT) and how this is
affected by ageing. Specifically, we wished to test the
hypothesis that cardiovascular risk factors have a greater
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impact on wave reflections in younger individuals but a
greater impact on aortic stiffness in older individuals.
Methods
Subjects were drawn from the ACCT study population, which
consists of 12 000 individuals, selected at random from local
general practice lists and open-access cardiovascular risk assessment
clinics, across East Anglia and Wales. The overall response rate was
85%. Subjects with secondary forms of hypertension or overt
cardiovascular disease were excluded, yielding a total of 4421
individuals for whom hemodynamic and biochemical data were
complete at the time of analysis.
Individuals were grouped according to the presence of the follow-
ing cardiovascular risk factors based on past history or confirmed at
the time of screening: hypertension (documented or brachial systolic
BP 140 mm Hg or brachial diastolic BP 90 mm Hg); hypercho-
lesterolemia (documented or fasting total cholesterol 6.2 mmol/L);
current smoking (1 cigarette per day); diabetes mellitus (World
Health Organization criteria) but without cardiovascular disease. The
presence of the metabolic syndrome was defined following guide-
lines from the International Diabetes Federation.17 Approval for all
studies was obtained from the local research ethics committees, and
written informed consent obtained from each participant.
Hemodynamics
BP was recorded in the dominant arm using a validated oscillometric
technique (HEM-705CP; Omron Corporation). Radial artery wave-
forms were recorded with a high-fidelity micromanometer (SPC-
301; Millar Instruments) from the wrist of the dominant arm. Pulse
wave analysis (SphygmoCor; AtCor Medical) was then used to
generate a corresponding central (ascending aortic) waveform using
a generalized transfer function,18 which has been prospectively
validated for the assessment of ascending aortic BP.19,20 Using the
integral software, augmented pressure was calculated as the differ-
ence between the second and first systolic peaks, and AIx was
calculated as augmented pressure expressed as a percentage of the
pulse pressure. Heart rate was determined from the aortic waveform,
and mean arterial pressure (MAP) was obtained by integration of
the waveform.
The aPWV was measured using the same device by sequentially
recording ECG-gated carotid and femoral artery waveforms, as
described in detail previously.21 Path length for the determination of
aPWV was measured as the surface distance between the supraster-
nal notch and femoral site minus the distance between the supraster-
nal notch and carotid site using a tape measure. All measurements
were made in duplicate by trained investigators, and the mean values
were used in the subsequent analysis. The within- and between-
observer measurement reproducibility values for AIx and aPWV
were in agreement with our previously published data.21
Protocol
Height and weight were assessed, and a medical history question-
naire including details of medication was completed. After 10
minutes of seated rest, brachial BP (clinic BP) and radial artery
waveforms were recorded in all subjects. After an additional 15
minutes of supine rest, brachial BP and radial artery waveforms were
remeasured and aPWV determined. Then 10 mL of blood was drawn
from the antecubital fossa into plain tubes. The samples were
centrifuged at 4°C (4000 rpm for 20 minutes) and the serum
separated and stored at 80°C for subsequent analysis. Cholesterol,
triglycerides, and glucose were determined using standard method-
ology in an accredited laboratory.
Data Analysis
Data were analyzed using SPSS software (version 12.0). To explore
the associations between traditional cardiovascular risk factors and
aPWV and AIx, 2 approaches were used. First, univariable and
stepwise multivariable regression models were constructed using the
entire study population and treating risk factors as dichotomous
(yes/no) variables. Then, using only untreated individuals, additional
stepwise multivariable regression models were constructed, treating
cardiovascular risk factors as continuous variables. Finally, the
influence of age on the relationship between cardiovascular risk
factors and arterial hemodynamics was examined by constructing
stepwise multivariable models including agerisk factor interaction
terms. Unless otherwise stated, aPWV has been adjusted for age,
gender, and MAP, and AIx has been adjusted for age, gender, height,
and heart rate. Where 1 component of BP was included in a
multivariable model, collinearity was assessed by the tolerance statistic
provided by SPSS, following Menard.22 All values represent
meansSD unless stated, and a P value 0.05 was considered
significant.
Results
The demographic and hemodynamic characteristics of the
study population are shown in Table 1 for all individuals and
for those not receiving medication.
Risk Factors as Dichotomous Variables
Traditional cardiovascular risk factors (hypertension, hyper-
cholesterolemia, smoking, and diabetes) were initially treated
as dichotomous (yes/no) variables, and the demographic and
hemodynamic characteristics were compared between indi-
viduals with and without each factor (Table 2). Because of
risk factor clustering, individuals with a designated risk factor
(eg, hypertension or smoking) were also more likely to have
increased levels of other risk factors (eg, higher total choles-
terol or glucose). After adjusting for confounding factors,
aPWV was significantly elevated in hypertensives, smokers,
and diabetics, whereas AIx was significantly elevated in
hypertensives, hypercholesterolemics, and smokers. More-
Table 1. Characteristics of Subjects Included in the Analyses
Parameter
All
n4421
Untreated
n3613
Age, y 4623 4122
Age range, y 18–92 18–92
Gender, male/female 2529/1892 1991/1622
Height, m 1.700.09 1.710.09
Weight, kg 7515 7315
Body mass index, kg/m2 25.64.6 25.04.38
Current smoker, % 17 15
Seated (clinic) SBP, mm Hg 13120 12819
Seated (clinic) DBP, mm Hg 7811 7811
Seated heart rate, bpm 7212 7212
Supine MAP, mm Hg 9214 9013
Supine heart rate, bpm 6711 6711
Supine augmentation index, % 1718 1418
Aortic PWV, m/s 7.922.99 7.342.66
Total cholesterol, mmol/L 4.721.15 4.651.16
LDL, mmol/L 2.710.97 2.670.98
HDL, mmol/L 1.420.40 1.430.40
Triglycerides, mmol/L 1.380.94 1.290.88
Glucose, mmol/L 5.191.56 5.001.24
Vasoactive therapy, % 18 …
Statin therapy, % 6 …
Data are meansSD. SBP indicates systolic BP; DBP, diastolic BP.
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over, individuals defined as having the metabolic syndrome
had a significantly elevated aPWV (8.491.31 m/s versus
8.172.14 m/s; P0.001) and AIx (1914% versus
1613%; P0.02) compared with those without the meta-
bolic syndrome (data not shown).
To compare the relative influence of each risk factor on
aPWV and AIx, univariable and multivariable analyses were
conducted. After initial adjustment for age and gender, the
presence of hypertension, smoking, and diabetes was associ-
ated with aPWV (Table 3). In a fully adjusted multivariable
model, diabetes, hypertension, and current smoking all remained
positively and independently associated with a PWV, together
with age, MAP, heart rate, and statin therapy. Gender and
hypercholesterolemia were inversely associated with aPWV.
Hypertension, hypercholesterolemia, and current smoking were
all positively associated with AIx in univariable analyses. All 3
risk factors remained independently associated with AIx in a
fully adjusted model, together with age, gender, heart rate mean
pressure, and height, although the associations between AIx and
heart rate, height, and hypertension were inverse. Tolerance
statistics indicated that collinearity between variables fell within
acceptable limits (data not shown).
Risk Factors as Continuous Variables
Risk factors were then treated as continuous rather than
dichotomous variables. In addition, only untreated individu-
als were included in additional analyses. This approach
allowed us to examine more fully the associations between
individual risk factors and arterial hemodynamics while
minimizing the potentially confounding influences of risk
factor clustering and medication on arterial hemodynamics
(Table 4). In fully adjusted models, clinic systolic BP and
Table 2. Characteristics of Individuals With and Without Traditional Cardiovascular Risk Factors
Parameter
Hypertension Hypercholesterolemia Smoking Diabetes
Yes
(n1827)
No
(n2594)
Yes
(n779)
No
(n3642)
Yes
(n733)
No
(n3688)
Yes
(n206)
No
(n4215)
Age, years 5919‡ 3621 6214‡ 4223 5323‡ 4423 6416‡ 4523
Gender, % male 67‡ 50 49‡ 59 72‡ 54 66† 57
Current smokers, % 20‡ 14 16‡ 17 100‡ 0 26‡ 16
Body mass index, kg/m2 27.74.6‡ 24.24.1 27.64.8 25.24.4 26.24.23‡ 25.54.7 29.45.5‡ 25.54.5
Clinic SBP, mm Hg 14817‡ 11911 14020‡ 12919 13419‡ 13020 14218‡ 13020
Clinic DBP, mm Hg 8512‡ 748 8211‡ 7711 7711† 7811 8011* 7811
aPWV, m/s§ 8.043.07‡ 7.611.94 7.662.24 7.802.81 8.003.34‡ 7.742.74 8.973.67‡ 7.872.88
AIx, %¶ 17.514.7‡ 14.617.7 17.013.4† 15.517.9 16.916.7† 15.518.3 17.012.4 16.318.1
Total cholesterol, mmol/L 5.101.12‡ 4.461.09 5.931.28‡ 4.440.92 4.781.11 4.701.16 4.701.04 4.721.15
Glucose, mmol/L 5.621.97‡ 4.901.12 5.491.90‡ 5.121.46 5.642.11‡ 5.101.41 8.754.10‡ 5.001.00
SBP indicates systolic BP; DBP, diastolic BP.
*P0.05, †P0.01, and ‡P0.001 vs individuals without the risk factor.
§Adjusted for age, gender, and MAP; ¶adjusted for age, gender, height, and heart rate.
Table 3. Univariable and Multivariable Regression Models for PWV and AIx, Considering Risk Factors as Dichotomous Variables
aPWV Beta R 2 Change P AIx Beta R 2 Change P
Univariable models Univariable models
Age, gender … … 0.001 Age, gender, height, HR … … 0.001
Hypertension, yes/no 0.20 … 0.001 Hypertension (yes/no) 0.08 … 0.001
Hypercholesterolemia, yes/no 0.01 … 0.3 Hypercholesterolemia (yes/no) 0.04 … 0.001
Smoking, yes/no 0.04 … 0.001 Smoking (yes/no) 0.03 … 0.001
Diabetes, yes/no 0.08 … 0.001 Diabetes (yes/no) 0.01 … 0.3
Multivariable model, adjusted R 2 0.68 Multivariable model, adjusted R 2 0.74
Age 0.61 60.7 0.001 Age 0.61 61 0.001
MAP 0.19 4.6 0.001 Gender 0.17 4.3 0.001
Heart rate 0.10 0.8 0.001 Heart rate 0.24 3.3 0.001
Gender 0.08 0.8 0.001 MAP 0.31 4.7 0.001
Diabetes, yes/no 0.07 0.6 0.001 Height 0.12 0.8 0.001
Hypertension, yes/no 0.06 0.2 0.001 Hypertension (yes/no) 0.06 0.2 0.001
Smoker, yes/no 0.03 0.1 0.003 Smoker (yes/no) 0.03 0.1 0.002
Statin therapy, yes/no 0.03 0.1 0.007 Hypercholesterolemia (yes/no) 0.02 0.1 0.004
Hypercholesterolemia, yes/no 0.02 0.1 0.008
Variables excluded: vasoactive therapy (aPWV); diabetes, statins, and vasoactive therapy (AIx).
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glucose levels were positively and independently associated
with aPWV, along with age, heart rate, and MAP. Clinic
diastolic BP was inversely associated with aPWV together with
gender. In contrast, clinic diastolic pressure and smoking were
positively and independently associated with AIx, together with
age, gender, and MAP, whereas clinic systolic pressure was
inversely associated with AIx, together with heart rate and
height. Again, the extent of collinearity between variables fell
within acceptable limits (data not shown).
Influence of Age on the Relationship Between Risk
Factors and aPWV and AIx
Using the same subset of untreated individuals, the influence
of age on the relationship between risk factors and aPWV and
AIx was then explored in a series of multivariable regression
models that included agerisk factor interaction terms (on-
line supplement, available at http://hyper.ahajournals.org). As
summarized in Table 4, there were significant interactions
between age and clinic systolic pressure, diastolic pressure,
pulse pressure, and glucose levels for aPWV. For AIx, there
were significant interactions between age and clinic systolic
pressure, diastolic pressure, and smoking. These interactions
are represented graphically in Figures 1 (aPWV) and 2 (AIx).
As illustrated in Figure 1, clinic systolic BP, pulse pressure,
and glucose were more strongly associated with aPWV in
older individuals, whereas the association with diastolic BP
was stronger in younger subjects. Figure 2 shows that the
associations between AIx and clinic systolic and diastolic BP
and smoking were more marked in younger individuals.
Discussion
We demonstrated in a single large population covering a wide
age range that BP exerts the most powerful influence on
arterial stiffness and wave reflections, but that traditional
cardiovascular risk factors have a much more modest effect
that is substantially influenced by age. Whereas BP and
glucose levels had a greater effect on arterial stiffness in older
individuals, BP and smoking had a greater effect on wave
reflections in younger individuals. These findings confirm
and extend our previous observations that arterial stiffness
and wave reflections are differentially affected by ageing.
The relationship between traditional cardiovascular risk
factors and large artery hemodynamics has been studied
widely in the past. Valuable cross-sectional data has been
provided by studies in hypertensives,6,23–32 chronic cigarette
smokers,11,12,33,34 asymptomatic individuals with hypercho-
lesterolemia9 and type I and type II diabetics,13–15,35–37 and in
relation to cholesterol38–42 and blood glucose levels.43 How-
ever, the findings from these studies have been inconsistent as
a result of small sample sizes, differing ages, variation in the
methodologies used to assess large artery properties, and the
lack of appropriate controls for confounding factors. More-
over, none of these studies considered whether ageing alters
the relationship between cardiovascular risk factors and
various arterial properties. Mitchell et al44 previously exam-
ined the prevalence and correlates of “abnormal” arterial
stiffness in pooled samples from the Framingham Heart
Study using an age-specific threshold criteria (90th percen-
tile for stiffness measures) derived from a reference sample of
healthy individuals. The authors observed that aPWV was
increased in 21% of men and 23% of women, and that the
major correlates of arterial stiffness were increased MAP,
abnormal glucose metabolism, lipid abnormalities, and obe-
sity. However, the average age of the pooled sample was63
years, and no age-specific information concerning the prev-
alence of abnormal stiffness in individuals 50 years of age
was provided. Moreover, the impact of cardiovascular risk
factors on wave reflections was not studied.
Table 4. Multivariable Regression Models for PWV and AIx in Untreated Individuals, Considering Risk Factors as Continuous Variables
aPWV Beta R2 Change P AIx Beta R2 Change P
Adjusted R 20.71 Adjusted R 2 0.73
Age 0.61 63.1 0.001 Age 0.60 59.9 0.001
Clinic SBP 0.16 5.4 0.001 Gender 0.13 4.0 0.001
Heart rate 0.08 0.9 0.001 MAP 0.38 3.0 0.001
MAP 0.22 0.5 0.001 Heart rate 0.22 4.1 0.001
Clinic DBP 0.12 0.8 0.001 Clinic systolic BP 0.20 1.4 0.001
Glucose 0.06 0.4 0.001 Height 0.12 0.7 0.001
Gender 0.06 0.3 0.001 Clinic diastolic BP 0.06 0.1 0.001
Smoking 0.03 0.1 0.001
Agerisk factor interactions* Agerisk factor interactions*
Ageclinic SBP 1.18 69.9 0.001 Ageclinic SBP 0.47 1.6 0.001
Ageclinic DBP 0.21 63.7 0.01 Ageclinic DBP 0.35 0.2 0.001
Ageclinic PP 0.72 67.1 0.001 Agesmoking 0.06 0.1 0.03
Ageglucose 0.34 1.2 0.001 Agetotal cholesterol 0.01 … 0.8
Agesmoking 0.01 … 0.2 Ageglucose 0.04 … 0.6
Agetotal cholesterol 0.01 … 0.9
SBP indicates systolic BP; DBP, diastolic BP; PP, pulse pressure.
Variables excluded: Height, weight, smoking, and total cholesterol (aPWV) and weight, total cholesterol, and glucose (AIx).
*Agerisk factor interactions are summarized here. Full risk factor interaction models appear in a supplemental table (http://hyper.ahajournals.org).
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In the current study, when risk factors were considered
dichotomous variables, aPWV was elevated in hypertensives,
smokers, and diabetics, and the presence of these risk factors
remained positively and independently associated with
aPWV in multivariable analyses. In contrast, AIx was ele-
vated in hypertensives, hypercholesterolemics, and smokers,
and again, these factors all remained independently associ-
ated with AIx in multivariable analyses, although the residual
association with hypertension was inverse. This may reflect a
predominant influence of isolated systolic hypertension,
which is the most common form of hypertension in young
adults and also those 60 years of age. Lower values of AIx
have been reported previously in young individuals with
isolated systolic hypertension, 45 and in older individuals, AIx
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Figure 1. Bar graphs representing the influence of age on the relationship between risk factors and aPWV. The bars represent stan-
dardized beta coefficients for the relationship between each risk factor and aPWV after adjustment for age, gender, and MAP. SBP
indicates systolic BP; DBP, diastolic BP; PP, pulse pressure.
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Figure 2. Bar graphs representing the influence of age on the relationship between risk factors and AIx. The bars represent standard-
ized beta coefficients for the relationship between each risk factor and AIx after adjustment for age, gender, height, and heart rate. SBP
indicates systolic BP; DBP, diastolic BP.
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is similar between patients with isolated systolic hypertension
and healthy controls.6 Nevertheless, our data are in agreement
with a wealth of previous studies in which risk factors have
been treated as dichotomous variables. However, as noted
many times previously, risk factors tend to cluster, even in
low-risk individuals.46 Indeed, in the current study, 20% of
individuals had 2 cardiovascular risk factors. This is im-
portant because defining the presence or absence of risk
factors by applying arbitrary criteria makes it very difficult to
determine the true nature of the associations between indi-
vidual risk factors and arterial properties.
To minimize the possible effects of risk factor clustering
and investigate more fully the influence of risk factors on
arterial properties, individual risk factors were then treated as
continuous rather than discrete variables. In addition, limiting
the analyses to those individuals not on drug therapy ex-
cluded the potentially confounding influence of drugs on
arterial properties. After adjusting for confounding factors,
clinic systolic and diastolic pressures and glucose levels were
independently associated with aPWV, whereas clinic systolic
and diastolic pressures and smoking were independently
associated with AIx. However, age and BP were most
strongly associated, accounting for 70% and 65% of the
explained variance in aPWV and AIx, respectively, with the
other cardiovascular risk factors having relatively little influ-
ence in either model. Overall, these observations underline
the dominant influence of age and BP in defining arterial
properties. Moreover, they provide direct empirical support
for the findings of a recent systematic review16 that suggested
that other than BP, the impact of traditional cardiovascular
risk factors on arterial stiffness was relatively modest.
Ageing exerts one of the most powerful influences on
arterial properties. However, our previous findings suggest
that there is a differential effect of age on arterial stiffness and
wave reflections, with a steeper age-related rise in aPWV in
older individuals and a steeper age-related rise in AIx in
younger individuals.3 In the current study, we extended these
findings by demonstrating a significant influence of age on
the relationship between risk factors and arterial stiffness and
wave reflections. The independent associations between
aPWV and clinic systolic BP, pulse pressure, and glucose
were all more marked in older individuals, although diastolic
BP was more strongly related to aPWV in younger subjects.
One potential explanation for these findings is that over time,
progressive aortic stiffening drives a decrease in diastolic
pressure and an increase in systolic and pulse pressure.
Indeed, as stated previously, isolated systolic hypertension is
a common condition in older individuals and one that is
characterized by increased aortic stiffening.6 In contrast to the
findings with aPWV, the associations between AIx and clinic
systolic and diastolic BP and smoking were all more marked
in younger individuals. Interestingly, outcome data from the
Framingham Heart Study47 support the view that aPWV is a
potent driver of cardiovascular risk in middle-aged and older
individuals, whereas AIx does not appear to be as strongly
related in this age group. Together, these findings suggest that
age exerts a differential effect on arterial hemodynamics. In
keeping with this observation, BP and other traditional
cardiovascular risk factors have a greater impact on wave
reflections in younger individuals but a greater impact on
aPWV in older individuals.
The present study has several limitations. First, the find-
ings are based on cross-sectional analyses, and longitudinal
data are clearly required to confirm the extent to which ageing
influences the impact of cardiovascular risk factors on arterial
hemodynamics. In addition, we cannot exclude the possibility
that increased arterial stiffness or wave reflections predis-
poses certain individuals to the development of cardiovascu-
lar risk factors or that risk factors and arterial measures are
both surrogate markers of underlying causal mechanisms.
Perspectives
Arterial stiffness and wave reflections and their relationship
with cardiovascular risk have been the focus of much recent
research. Arterial measures such as aPWV and AIx, which are
widely used to quantify aortic stiffness and wave reflections,
are noninvasive, easy to use, and do not require calibration,
making them ideal for routine clinical use. Many previous
studies explored the links between arterial properties and
traditional cardiovascular risk factors using defined groups of
patients such as hypertensives or hypercholesterolemics.
However, the findings of these studies are difficult to inter-
pret because of the inherent confounding effects of risk factor
clustering. We explored the continuous relationship between
risk factors and arterial properties in a large cohort of
individuals across a wide spectrum of age and have demon-
strated that the impact of traditional cardiovascular risk
factors on arterial stiffness and wave reflections is strongly
dependent on age and is driven predominantly by BP.
Additional outcome studies are required to confirm the
differential impact of these arterial measures on cardiovascu-
lar risk within a single population.
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S1: Multivariable regression models investigating the influence of age on the relationship between 
risk factors and aPWV and AIx. 
aPWV Beta R2 
Change 
P  AIx Beta R
2 
Change 
P 
Clinic SBP     Clinic SBP    
Age x clinic SBP 1.18 69.9 <0.001  Age  0.99 59.9 <0.001 
Heart rate 0.08 1.1 <0.001  Gender 0.14 4.0 <0.001 
Gender -0.10 0.9 <0.001  MAP 0.40 3.0 <0.001 
MAP 0.18 0.4 <0.001  Heart rate -0.22 4.1 <0.001 
Clinic DBP -0.06 0.4 <0.001  Age x clinic SBP -0.47 1.6 <0.001 
Glucose 0.06 0.3 <0.001  Height -0.12 0.8 <0.001 
Clinic SBP -0.15 <0.1 <0.001  Smoker 0.03 0.1 0.001 
Age -0.39 0.3 <0.001  Clinic SBP -0.01 <0.1 0.008 
     Clinic DBP 0.03 <0.1 0.029 
         
Clinic DBP     Clinic DBP    
Age x clinic DBP -0.209 63.7 0.011  Age 0.92 59.9 <0.001 
Clinic SBP 0.16 2.0 <0.001  Gender 0.14 4.0 <0.001 
Age 0.41 2.8 <0.001  MAP 0.38 3.0 <0.001 
Heart rate 0.08 0.9 <0.001  Heart rate -0.22 4.1 <0.001 
MAP 0.22 0.5 <0.001  Clinic SBP -0.19 1.4 <0.001 
Clinic DBP -0.16 0.5 <0.001  Height -0.12 0.7 <0.001 
Glucose 0.06 0.4 <0.001  Clinic DBP 0.13 0.1 <0.001 
Gender -0.06 0.3 <0.001  Age x DBP -0.35 0.2 <0.001 
     Smoker 0.03 0.1 0.001 
         
Glucose     Glucose    
Age 0.35 63.1 <0.001  Age 0.60 59.9 <0.001 
Clinic SBP 0.16 5.4 <0.001  Gender 0.13 4.0 <0.001 
Age x Glucose 0.34 1.2 <0.001  MAP 0.38 3.0 <0.001 
MAP 0.22 0.8 <0.001  Heart rate -0.22 4.1 <0.001 
Clinic DBP -0.11 0.5 <0.001  Clinic SBP -0.20 1.4 <0.001 
Heart rate 0.08 0.5 <0.001  Height -0.12 0.7 <0.001 
Gender -0.06 0.3 <0.001  Clinic DBP 0.06 0.1 <0.001 
Glucose -0.10 0.2 <0.001  Smoking 0.03 0.1 0.001 
     Glucose -0.01 - 0.5 
     Age x Glucose -0.04 - 0.6 
         
Total Cholesterol     Total Cholesterol    
Age 0.60 63.1 <0.001  Age 0.60 59.9 <0.001 
Clinic SBP 0.16 5.4 <0.001  Gender 0.13 4.0 <0.001 
Heart rate 0.08 0.9 <0.001  MAP 0.38 3.0 <0.001 
MAP 0.22 0.5 <0.001  Heart rate -0.22 4.1 <0.001 
Clinic DBP -0.12 0.8 <0.001  Clinic SBP -0.20 1.4 <0.001 
Glucose 0.06 0.4 <0.001  Height -0.12 0.7 <0.001 
Gender -0.06 0.3 <0.001  Clinic DBP 0.06 0.1 <0.001 
Cholesterol -0.007 - 0.6  Smoking 0.03 0.1 0.001 
Age x Cholesterol 0.006 - 0.9  Cholesterol 0.01 - 0.6 
     Age x Cholesterol 0.01 - 0.8 
  
         
         
aPWV Beta R2 
Change 
P  AIx Beta R
2 
Change 
P 
Smoking     Smoking    
Age 0.60 63.1 <0.001  Age 0.61 59.9 <0.001 
Clinic SBP 0.16 5.4 <0.001  Gender 0.13 4.0 <0.001 
Heart rate 0.08 0.9 <0.001  MAP 0.38 3.0 <0.001 
MAP 0.22 0.5 <0.001  Heart rate -0.22 4.1 <0.001 
Clinic DBP -0.12 0.8 <0.001  Clinic SBP -0.20 1.4 <0.001 
Glucose 0.06 0.4 <0.001  Height -0.12 0.7 <0.001 
Gender -0.06 0.3 <0.001  Clinic DBP 0.05 0.1 <0.001 
Smoking 0.003 - 0.9  Smoking 0.08 0.1 0.001 
Age x smoking 0.013 - 0.2  Age x smoking -0.06 <0.1 0.03 
         
